Gemmus Pharma Receives Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7ffcaf3-c702-48fa-a8cf-685dfb7cc8b1&Preview=1 - Date
6/29/2012 - Company Name
Gemmus Pharma - Mailing Address
409 Illinois Street San Francisco, CA 94158 - Company Description
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. - Website
http://www.gemmuspharma.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Life Science Angels - Venture Investor
BlueTree Allied Angels - Venture Investor
Tech Coast Angels - Venture Investor
Wilmington Investor Network - Venture Investor
The Angels’ Forum
